SLONIN JONATHAN sold PCRX
August 17, 2026 · Form 4 insider transaction
SLONIN JONATHAN sold 3,040 shares of Pacira BioSciences, Inc. at $23.23 per share, a transaction worth $70.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,040
Price
$23.23
Total value
$70.6K
InsiderSLONIN JONATHAN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 17, 2026
Filing dateAugust 18, 2026
Shares owned after216,384
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025.; Includes 511.471 shares of common stock acquired under the issuer's employee stock purchase plan in June 2026.